Sr. Director, Quantitative Pharmacology 1 of 2
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, NY, United States
- Start date
- Sep 16, 2020
View more
- Discipline
- Science/R&D, Pharmacology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
JOB DUTIES
- Accountable for developing a culture encouraging of MIDD approaches at Regeneron, influencing key partners, stakeholders and regulators of its value and application
- Accountable for planning and executing state-of-the-art M&S techniques with direct value for projects cross the portfolio
- Scientific and strategic input into pre-clinical, clinical, and post-approval development plans
- Accountable for oversight, support and delivery of scientific and strategic modeling work related to specific projects
- Support evaluation of drug candidates for in/out-licensing
- Accountable for the identification and development of drug-disease models and other modeling approaches to support internal and external decision making in collaboration with partners (when relevant)
- Accountable to provide peer review and mentoring of junior staff
- Support and contribute to the development of the quantitative pharmacology in terms of providing training and knowledge sharing
- Monitoring external and internal environment in terms of relevant new methodologies and applications
- Increase Regeneron profile externally in the area of MIDD by speaking at external events and by publication in recognized external journals
- Ensure Regeneron modeling efforts are aligned with current regulatory expectation
- Partner with the Preclinical Pharmacokinetic/Pharmacodynamics Team to enable translational PKPD efforts in the Discovery space
REQUIREMENTS
Education
This position requires a PhD in Pharmaceutical Sciences (PKPD emphasis), Statistics, Engineering or other quantitative subject areas. 15 years validated experience in the application of QP in a drug discovery/development setting including experience in developing PhD modelers is required. This experience should include noteworthy expertise in M&S, including PK, PKPD and Statistics. Broad Translational and Clinical development expertise in drug development (early and late), with emphasis on Pharmacometrics is required.
The candidate will have an international reputation gained from publishing in the field on Pharmacometrics as well as a track record of identifying, developing and executing portfolio-level M&S activities and disease domain knowledge.
A confirmed knowledge of Regulatory, compliance, processes, standards and Pharmacometrics issues as well as Regulatory experience (written/oral) is desired.
Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides amazing benefits including health and wellness programs, fitness centers and stock for employees at all levels!
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or maternity status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.
-
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert